GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,314,826 | -28.3% | 1,666,181 | +4.0% | 0.32% | -32.4% |
| Q2 2023 | $8,809,713 | +27.9% | 1,601,766 | 0.0% | 0.48% | +75.0% |
| Q1 2023 | $6,887,594 | +47.7% | 1,601,766 | +35.0% | 0.27% | +32.0% |
| Q4 2022 | $4,662,139 | -12.0% | 1,186,295 | +18.9% | 0.21% | -37.0% |
| Q3 2022 | $5,299,000 | -68.9% | 997,857 | -61.6% | 0.33% | -66.4% |
| Q2 2022 | $17,040,000 | -10.6% | 2,597,631 | 0.0% | 0.97% | +12.0% |
| Q1 2022 | $19,067,000 | +36.3% | 2,597,631 | +31.5% | 0.87% | +22.0% |
| Q4 2021 | $13,984,000 | -65.1% | 1,975,146 | +23.5% | 0.71% | -63.9% |
| Q3 2021 | $40,106,000 | +5.3% | 1,599,774 | +12.9% | 1.97% | +28.8% |
| Q2 2021 | $38,103,000 | – | 1,416,483 | – | 1.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $32,535,983 | 3.92% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $4,018,570 | 0.79% |
| Artal Group S.A. | 2,814,191 | $11,060 | 0.62% |
| SVB FINANCIAL GROUP | 52,920 | $207,976 | 0.57% |
| PFM Health Sciences, LP | 2,903,192 | $11,409,545 | 0.41% |
| Cheyne Capital Management (UK) LLP | 51,126 | $200,925 | 0.35% |
| HighVista Strategies LLC | 138,880 | $545,798 | 0.32% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,005,691 | 0.25% |
| SECTORAL ASSET MANAGEMENT INC | 273,787 | $1,075,983 | 0.21% |
| Yiheng Capital Management, L.P. | 1,186,295 | $4,662,139 | 0.21% |